The Access to Comprehensive Genomic Profiling Coalition Adds New Member News provided by Share this article Share this article WASHINGTON, May 20, 2021 /PRNewswire/ -- The Access to Comprehensive Genomic Profiling Coalition (ACGP) announced today the addition of Mayo Clinic Laboratories to its coalition of diagnostics companies and laboratory service providers to advocate for appropriate broad U.S. health insurance coverage of comprehensive genomic profiling (CGP) for patients living with advanced cancer. "On behalf of ACGP, we welcome Mayo Clinic Laboratories to the coalition working to advocate for access to comprehensive genomic profiling (CGP) for patients living with advanced cancer," said Jim Almas, MD, vice president and national medical director of clinical effectiveness at Labcorp, and chairman of ACGP. "The addition of Mayo Clinic Laboratories, a recognized global reference laboratory that supports patient care and access to specialized testing, is further evidence of growing stakeholder interest in improving access to CGP."